GIANNA NETTIS: Open Payments
NPI 1336985688 · PEMBROKE, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$210 in 12 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $524 · 2025 $210
Food & beverage: $210
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $47 |
| ABBVIE INC. | 3 | $46 |
| Teva Pharmaceuticals USA, Inc. | 2 | $40 |
| Axsome Therapeutics, Inc. | 1 | $30 |
| Janssen Pharmaceuticals, Inc | 1 | $17 |
| Vanda Pharmaceuticals Inc. | 1 | $16 |
| Otsuka America Pharmaceutical, Inc. | 1 | $15 |
Products named: CAPLYTA, VRAYLAR, Auvelity, UZEDY, AUSTEDO XR, INVEGA SUSTENNA, FANAPT, ABILIFY MAINTENA.
Industry payments across MA — which companies pay providers there.
